Sedative Use Disorder: Research and Practice - 2023
- Non-Member - $39
- Regular Member - $29
- Retired - $29
- Early Career Physician - $29
- Resident - $19
- Student - $19
- Associate - $19
- ASAM Staff - Free!
- International Member - $29
- Emeritus Member - $29
- Provisional Member - $29
- Fellow Member - $29
- Honorary Member - $29
- CRT Member - $29
Sedative Use Disorder: Research and Practice
Recorded: Thursday, July 27, 2023 - Friday, July 28, 2023
This 45-minute, on-demand session from the ASAM 2023 Review Course reviews the pharmacokinetics of sedatives, growing prevalence of sedative use, and discusses the risks and benefits of sedative use as well as treatment strategies for sedative withdrawal.
Sedatives are one of the most frequently prescribed and frequently misused substances. This session will review the pharmacokinetics of sedatives and growing prevalence of sedative use. The presenter will discuss the risks and benefits of sedative use including the concerns around related syndromes and polysubstance use. Participants will also learn treatment strategies for sedative withdrawal. After this session, learners will be able to describe the neurobiological impacts of sedatives, criteria for sedatives use disorder, and evidence-based treatment strategies.
The target audience for this introductory and intermediate-level activity includes: Physicians preparing for the ABPM or AOA Board Certification Examination in addiction medicine, nurse practitioners, physician assistants, other clinicians, researchers, residents, fellows, students, and counselors.
This activity addresses the following ACGME Competencies: Patient Care, Medical Knowledge, and Practice-Based Learning.
Upon completion, learners will be able to:
- Demonstrate practical knowledge on the neurobiology of addiction and articulate its activity in terms useful in a clinical setting.
- Describe the effects of alcohol, tobacco and other drugs in both tolerant and non-tolerant individuals.
- Describe the process for diagnosing addiction and differentiating the symptoms of addiction from those of other medical or psychiatric disorders.
- Explain the various pharmacologic and psychosocial treatments for addictive disorders and describe the factors that should be considered in selecting a treatment modality to match the needs of a specific patient.
- Describe the precipitants of relapse and current evidence-based practices to prevent and manage relapse.
*Residents, Fellows-in-training, Interns, and Students must join ASAM to receive a discounted registration rate. Click here to become an ASAM member. National and Chapter membership dues apply. There is no charge for Students to become a Member, but verification of student status is required.
Refunds & Cancellations
All ASAM e-Learning Center refund requests must be made in writing to firstname.lastname@example.org within 90 days of purchase. Those requesting refunds for courses that are in progress will receive partial refunds or e-Learning Center credit. Automatic full refunds will be made for any course with a live-course component that has been cancelled.
Registration Deadline: 07/31/2026
Registrant Access Closed: 07/31/2026
- Click on the Contents tab to watch the on-demand recording.
- Click Complete Post Test to answer multiple choice questions. Participants will have 10 attempts to pass and must answer 2 out of 3 questions correctly.
- Click Complete Evaluation to provide valuable activity feedback. Scroll down on all questions as there may be answer options that expand past the size of the window.
- Click the button Claim Medical Credits in the box titled Claim Credits & Certificate. Choose the type of credit and click submit. Click the button View/Print Certificate to save or print your certificate. You can view/print your certificate at any time by visiting the ASAM eLearning Center, clicking Dashboard, and clicking Transcript/Achievements.
ASAM is proud to offer Essential Accessibility to ensure our website is accessible and functional for all our learners while providing free assistive technology for people with the widest possible range of abilities.
Ricardo Restrepo, MD, MPH finished his medical school in Medellín, Colombia. He then did his residency training in Psychiatry at Boston University Medical Center where he completed a fellowship in Addiction Psychiatry. He received an MPH in Global Public Health from NYU in 2008, while working at St Luke’s/Roosevelt Hospital, where he was Director of the Addiction Psychopharmacology Clinic at the Addiction Institute of New York.
Since 2012, he works at the Long Beach VA Hospital, where he is the Medical Director of the SATP/Buprenorphine Clinic. Ricardo holds an academic position as Associate Clinical Professor of Psychiatry at the University of California (Irvine and Riverside) School of Medicine and most recently at the Charles Drew University, Los Angeles. He teaches and supervises students, psychiatry, family medicine and internal medicine residents. He serves as committee member of the American Academy of Addiction Medicine (AAAP) as well as on the California Society of Addiction Medicine (CSAM) Conference planning committee.
Ricardo's academic interests include the psychotherapy and psychopharmacology of addiction and the teaching of Psychiatry and Addiction Medicine. He is actively involved in issues related to transcultural psychiatry and behavioral addictions. He has worked with immigrant populations in the United States for over 20 years. As a volunteer for Physicians for Human Rights (PHR), he has participated in projects in the United States, Latin America and the Middle East. He has served as a United Nations Consultant since 2005.
Dr. Restrepo has written chapters on addiction and human rights textbooks. He is the co-author of textbooks on buprenorphine as well as women’s health and addiction, and he cooperated with the Translation of DSM-5 to Spanish. He is board re-certified in Psychiatry and Addiction Psychiatry and a professional musician.
No Relevant Financial Disclosures
CME, CE, CEU and Other Credit Types
ACCME Accreditation Statement
The American Society of Addiction Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
AMA Credit Designation Statement
The American Society of Addiction Medicine designates this enduring material for a maximum of 0.75 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
California Association for Drug/Alcohol Educators (CAADE)
This educational program is approved by CAADE: #CP40 999 1225
California Association of DUI Treatment Centers (CADTP)
This educational program is approved by CADTP: #205
California Consortium of Addiction Programs and Professionals (CCAPP)
This educational program is approved by CCAPP: #OS-20-330-1224
Continuing Education Credits (CEUs)
Non-physician participants will receive a certificate of attendance upon completion of the activity and an online evaluation confirming their participation. Participants should submit his/her certificate of attendance to their professional organization/institute.
Maintenance of Certification (MOC) or Continuing Certification Programs (CCP)
This activity meets the requirements for MOC/CCP for the following primary physician boards and for state licensing CME requirements. MOC Credit is only reported for ABA, ABP, ABIM, and ABS. Learn more.
- American Board of Medical Specialties (ABMS)
- American Board of Preventive Medicine (ABPM)
- American Board of Anesthesiology (ABA)
- American Board of Internal Medicine (ABIM)
- American Board of Pediatrics (ABP)
- American Board of Surgery (ABS)
- American Board of Psychiatry and Neurology (ABPN)
- American Board of Addiction Medicine (ABAM)
- Royal College of Physicians and Surgeons of Canada (RCPSC)
In accordance with disclosure policies of ASAM and the ACCME, the effort is made to ensure balance, independence, objectivity, and scientific rigor in all CME activities. These policies include mitigating all possible relevant financial relationships with ineligible companies for the Planning Committees and Presenters. All activity Planning Committee member and Presenters have disclosed relevant financial relationship information. The ASAM CME Committee has reviewed these disclosures and determined that the relationships are not inappropriate in the context of their respective presentations and are not inconsistent with the educational goals and integrity of the activity. View all faculty disclosure information here.
|Access Date||Quiz Result||Score||Actions|